Laser Photonics Corp. — Form 10-Q Summary
Reporting period: Three months ended March 31, 2021. The company manufactures photonics-based industrial products, primarily laser cleaning equipment, and describes plans to develop standardized Laser Tower laser-cutting systems. Comparative operating and cash-flow figures are for the three months ended March 31, 2020.
Financial results and position
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Revenue | $976,025 | $177,925 |
| Gross profit | $623,988 | $120,605 |
| Gross margin | About 63.9% | About 67.8% |
| Net income (loss) | $182,003 | $(155,651) |
| EBITDA, as reported | $238,241 | $(145,985) |
| Operating cash flow | $(171,550) | $(363,725) |
- Revenue increased about 449% year over year. Management attributed the rise primarily to higher sales of the Roughing high-power 2000CTH model and increased acceptance of laser blasting by U.S. agencies and industries.
- Gross profit rose substantially, but gross margin declined to about 63.9% from 67.8%. Operating expenses were $441,986, up from $276,257; payroll expense increased by about $64,068, mainly due to additional system-assembly personnel.
- Cash was $380,772 at March 31, 2021, versus $326,713 at December 31, 2020. Current assets were $2,987,201 and current liabilities $353,162. The balance sheet therefore implies working capital of $2,634,039.
- Total liabilities were $1,670,826, including $876,309 owed on ICT Investments notes, $397,500 in PPP loans, and lease liabilities. The ICT notes bear 6% interest; PPP loans bear 1% if not forgiven.
- Cash increased by $54,059 during the quarter. The company reported operating cash use of $171,550 and financing cash inflow of $148,291; the cash-flow statement reports investing cash inflow of $77,318.
Changes, outlook, and risks
- The company moved from a year-earlier quarterly loss to net income, while revenue and gross profit increased materially. Operating cash flow nevertheless remained negative.
- Management expects near-term selling costs to rise to support growth and expects cost of sales to decline over time with higher production volumes, component availability, and manufacturing efficiencies. The filing provides no quantified revenue, earnings, or cash-flow guidance.
- The company received a second-draw PPP loan of $198,750 on March 26, 2021, bringing aggregate PPP proceeds to $397,500. Management anticipated that most of the loans would be forgiven, but stated there was no assurance of forgiveness.
- COVID-19 could adversely affect future operating results, financial position, liquidity, and asset values. Inventory includes specialized components subject to obsolescence and substantial sales-demonstration inventory; a sharp sales decline could affect inventory recoverability.
- The company leases manufacturing space from ICT Investments for approximately $14,378 per month; the disclosed sublease commitment runs through October 2021. Management also identifies public-company compliance demands as a potential constraint on time available to execute its growth plans.
- The filing reports no material legal proceedings, subsequent events, or material off-balance-sheet arrangements. Management stated disclosure controls were effective; the filing did not include an auditor attestation on internal control over financial reporting.
Important facts for investors to verify
- Cost-of-sales discrepancy: The financial statements report cost of goods sold of $352,037, consistent with reported gross profit of $623,988. A later MD&A passage instead says cost of goods sold was $214,227.
- Share-count and earnings-per-share figures: The filing cover reports 3,561,316 shares outstanding at March 31, 2021, while the statements report weighted-average shares of 29,270,502 and the shareholders’ equity schedule also shows 29,270,502 shares. Reported net income per share is shown as zero. Clarify the share count and per-share calculation.
- Liquidity disclosure: MD&A reports total working capital of $3,014,811, but current assets less current liabilities equals $2,634,039; the filing’s own table labels $2,634,039 as working capital excluding cash and then adds cash. Confirm the intended measure.
- Debt and liability balances: Some note disclosures contain liability totals and comparison dates that do not align with the balance sheet. Reconcile the reported total liabilities, ICT note balances, and PPP classification.
- Cash-flow presentation: The statement labels investing cash flow as positive $77,318 despite listing investing-related adjustments, including depreciation and right-of-use-asset changes. Confirm the classification and underlying cash flows.
- Customer concentration and sales quality: Management names AMMO, Blue Origin, SPX, Illumina, and Excet c/o Naval Research Laboratory among its largest sales. The filing does not quantify customer-by-customer revenue concentration.